Of the Field

Festival of Biologics USA 2027

T

he Festival of Biologics USA is America’s most comprehensive biologics event, covering the entire industry from antibody therapies, cell and gene therapies, immunotherapies, to biosimilars. It brings together 2,000+ attendees from pharma, biotech, start-ups, academia, regulators and investors for two days of presentations, panels, networking, and workshops.…

Visit the official siteRegister
89Voices
61Underwriters
1Exhibitors
8On the bill · sessions
98Companies · in total
§I

The Voices

Programmed at Festival, in alphabetical order.
Aamer Ejaz
Group Vice President, Carrier Business (PTCL & Ufone) · Pakistan Telecommunication Company Limited (PTCL)
Adam Ball
General Manager · Terrapinn
Adrian Hugenmatter
Stanford University
Afifa Dean
Head, Media Management · Telekom Malaysia
Ahmed Saady Yaamin
Group Head of AI and Analytics · Axiata Group
Andrew Tsourkas
Professor of Bioengineering · University of Pennsylvania
Anne Kerber
Senior Vice President, Head Cell Therapy Development · Bristol Myers Squibb
Aps Chikhalikar
Head of Telecom, Media and Technology, AP&J · ServiceNow
Ayomal Gunasekera
Chief of Group Customer Experience · Dialog Axiata PLC
Brajesh Bhagat
Global Category Manager - Network Services · Telenor Procurement Company
Brian Avanzino
Director of Discovery Research · Rondo Therapeutics
Changchun Du
Senior Principal Scientific Researcher · Genentech
Cheryl Marcotte
Sr Director · GSK
Chris Mason
Professor of Cell and Gene Therapy · UCL
Daniela Cipolletta
Senior Director of Immunology · Seismic Therapeutic
Danny Han Seng Foong
SVP, Head of Commercial Portfolio & Strategy Execution · True Corporation
Dinie Rahimi Che Ayob
Cloud Communications Sales & Business Development Director APAC · Deutsche Telekom T Wholesale
Dirk Zajonc
Exec Dir, Protein Engineering · Mirador Therapeutics
Ekaraj Panjavinin
Chief Digital Officer · True corporation
Emanuela Lacana
Deputy Director, Office of Therapeutic Biologics and Biosimilars/ OND/ CDER · FDA
Eugene Zhukovsy
Vice President and Site Head of Biologics R&D · Orion Pharma
Faisal Ahmed
Digital Platforms & Engineering Director · Banglalink

— and 67 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
3T Biosciences
AbbVie
AIVITA Biomedical, Inc.
AlivaMab Discovery Services
Amgen
Amsterdam UMC
Arscientia
Biodesign Institute at Arizona State University
Biogen
Biolojic Design
BioTalent
Bristol Myers Squibb
Buzz Biolabs
Diachi Sankyo
Eli Lilly
Exreprotein LLC
Fate Therapeutics
FDA
Fred Hutch
Fujifilm
Genentech
Genevation LTD
Gilead
Gritstone Bio
GSK
Icosagen
Immunogen
ImYoo Health
Ipca Laboratories Ltd
isla
John Hopkins University
Kennesaw State University
Lasanth Consulting
Mayo Clinic
Memorial Sloan-Kettering Cancer Center
Mirador Therapeutics
MJH Life Sciences
MSKCC
Mucommune
Northeastern University
§III

The Programme

Selected from 8 sessions on the bill.
  • Nov 18 11:40

    Ai-driven strategies for the next-gen cloud: Building the telecom playbook

    NETWORK
  • Nov 18 11:40

    AI in action — Personalising services and transforming customer experience

    CUSTOMER
  • Nov 18 11:40

    Infrastructure sharing models: Collaborating and competing

    THE TELCO BOARDROOM
  • Nov 18 12:00

    PANEL: From predicting problems to optimising outcomes and delivering dollars — is AI the answer?

    THE TELCO BOARDROOM
  • Nov 18 12:00

    PANEL: NaaS for telco operators in Asia: Cloud first, cloud only?

    NETWORK
  • Nov 18 12:00

    The Telco AI Trifecta – Enabling autonomous, customer-centric networks

    CUSTOMER
  • Nov 18 9:15

    Organiser’s Welcome

    Keynotes
  • Nov 18 9:30

    KEYNOTE PANEL: AI — faster, leaner, smarter... is the telco of tomorrow already today?

    Keynotes
Intermission
Part the Second · For the Buyer

What does it mean when 98 companies show up — and 44 bet on three roles at once?

98 companies. 44 are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
44All threespeak · spons · exh
17Sponsoringsponsor only
1Exhibitingexhibitor only
36Companies Speakingspeaker only

The Triple-Threat

FDA·Rondo Therapeutics·Sanofi·University of California, San Diego·3T Biosciences·AbbVie·AIVITA Biomedical, Inc.·AlivaMab Discovery Services·Amsterdam UMC·Biodesign Institute at Arizona State University·Biolojic Design·BioTalent·Bristol Myers Squibb·Buzz Biolabs·Eli Lilly·Fate Therapeutics·Fred Hutch·Genentech·Genevation LTD·GSK·Immunogen·ImYoo Health

02Fig. 02 — The Voices, by Seniority

69% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite1112%
  • Founder / Owner33%
  • VP-level1315%
  • Director / Head of3438%
  • Manager / Lead56%
  • Research / Science44%
  • Advisor / Investor22%
  • Other roles1719%

Of 89 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 01FDASp2V
  2. 02Rondo TherapeuticsSp2V
  3. 03SanofiSp2V
  4. 04University of California, San DiegoSp2V
  5. 053T BiosciencesSp1V
  6. 06AbbVieSp1V
  7. 07AIVITA Biomedical, Inc.Sp1V
  8. 08AlivaMab Discovery ServicesSp1V
  9. 09Amsterdam UMCSp1V
  10. 10Biodesign Institute at Arizona State UniversitySp1V
  11. 11Biolojic DesignSp1V
  12. 12BioTalentSp1V
  13. 13Bristol Myers SquibbSp1V
  14. 14Buzz BiolabsSp1V
04Fig. 04 — By Tier
unspecified61
100% of 61
05Fig. 05 — The Missing · who's at peer events but not here

These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.

06Fig. 06 — Adjacent Convocations · by shared underwriters